To evaluate the current status of cancer mortality following the initiation of HP2020, CDC scientists evaluated population trends and made projections on cancer deaths based on race and gender.
Healthy People 2020 (HP2020), an initiative of the US Department of Health and Human Services, was introduced to:
a 10% to 15% reduction in cancer death rates from 2007 till 2020.
Each objective of HP2020 has a baseline measure and a target to be achieved by 2020, including
To evaluate the current status of cancer mortality following the initiation of HP2020, CDC scientists used mortality data from 1995 to 2009 and evaluated population trends and made projections on cancer deaths based on race and gender.
2007 and 2020
According to the report, published in Preventing Chronic Disease, age-standardized death rates (population risk) began declining in the early 1990s and will continue to decline through 2020 for all cancer sites combined and for many of the leading cancers in both men and women. However, the report estimates a >10% increase in cancer deaths between among men and black women, and melanoma appears to have worse results.
The report concludes that while the overall risk of dying from cancer is declining, the impact of underlying demographic changes in the population will increase the burden of cancer on society and healthcare systems. This, the authors conclude necessitates "increased efforts to promote cancer prevention and improve survival to counter the impact of a growing and aging population on the cancer burden and to meet melanoma target death rates."
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More